These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
552 related items for PubMed ID: 8053058
21. Depletion of complement in xenograft retransplantation. Tufveson G, Gustavsson M, Nilsson B, Karlsson-Parra A, Samuelsson B, Gannedahl G. Transplant Proc; 1994 Apr; 26(2):1020-1. PubMed ID: 8171454 [No Abstract] [Full Text] [Related]
23. Suppressor cells induced by donor-specific transfusion and deoxyspergualin in rat cardiac xenografts. Valdivia LA, Monden M, Gotoh M, Tono T, Nakano Y, Mori T. Transplantation; 1991 Oct; 52(4):594-9. PubMed ID: 1833863 [Abstract] [Full Text] [Related]
27. Inhibition of the membrane attack complex of complement for induction of accommodation in the hamster-to-rat heart transplant model. Suhr BD, Black SM, Guzman-Paz M, Matas AJ, Dalmasso AP. Xenotransplantation; 2007 Nov; 14(6):572-9. PubMed ID: 17991145 [Abstract] [Full Text] [Related]
28. Evidence that 15-deoxyspergualin inhibits natural antibody production but fails to prevent hyperacute rejection in a discordant xenograft model. Leventhal JR, Flores HC, Gruber SA, Figueroa J, Platt JL, Manivel JC, Bach FH, Matas AJ, Bolman RM. Transplantation; 1992 Jul; 54(1):26-31. PubMed ID: 1631940 [Abstract] [Full Text] [Related]
30. Prolongation of survival of guinea pig heart grafts in cobra venom factor-treated rats by splenectomy. No additional effect of cyclosporine. Scheringa M, Schraa EO, Bouwman E, van Dijk H, Melief MJ, Ijzermans JN, Marquet RL. Transplantation; 1995 Dec 15; 60(11):1350-3. PubMed ID: 8525534 [No Abstract] [Full Text] [Related]
31. Mechanism of leflunomide-induced prevention of xenoantibody formation and xenograft rejection in the hamster to rat heart transplantation model. Lin Y, Sobis H, Vandeputte M, Waer M. Transplant Proc; 1995 Feb 15; 27(1):305-6. PubMed ID: 7879012 [No Abstract] [Full Text] [Related]
34. Anti-major histocompatibility complex class II treatment prevents graft rejection in the hamster-to-rat cardiac xenograft. Saxton NE, Hallaway RV, Ladyman HM, Janczynski BT, Nesbitt AM, Zinkewich-Peotti K, Smith R, Foulkes R. Transplantation; 1999 Jun 27; 67(12):1599-606. PubMed ID: 10401768 [Abstract] [Full Text] [Related]
35. Vascular transplantation of Syrian hamster heart into Lewis rat: effect of brequinar, cyclosporine, cobra venom factor, and splenectomy. Schuurman HJ, Joergensen J, Kuipers H, Meerloo T, Lardelli P, Hiestand P, White DH, Schreier MH. Transplant Proc; 1994 Jun 27; 26(3):1217-9. PubMed ID: 8029893 [No Abstract] [Full Text] [Related]
36. [Experimental study of the effectiveness of immunosuppression therapy using FK506 and 15-deoxyspergualin in concordant xenotransplantation]. Maeda T. Nihon Kyobu Geka Gakkai Zasshi; 1997 Jun 27; 45(6):841-5. PubMed ID: 9217381 [Abstract] [Full Text] [Related]
37. Intragraft cytokine mRNA expression in rejecting and non-rejecting vascularized xenografts. Lorant T, Krook H, Wilton J, Olausson M, Tufveson G, Korsgren O, Johnsson C. Xenotransplantation; 2003 Jul 27; 10(4):311-24. PubMed ID: 12795680 [Abstract] [Full Text] [Related]
38. Inhibition of rejection of hamster-to-rat heart xenografts. Hasan R, van den Bogaerde J, Forty J, Wright L, Wallwork J, White DJ. Transpl Int; 1992 Jul 27; 5 Suppl 1():S313-7. PubMed ID: 14621810 [Abstract] [Full Text] [Related]
39. Delayed xenograft rejection in C3-depleted discordant (pig-to-baboon) cardiac xenografts treated with cobra venom factor. Kobayashi T, Taniguchi S, Ye Y, Niekrasz M, Kosanke S, Neethling FA, Wright LJ, Rose AG, White DJ, Cooper DK. Transplant Proc; 1996 Apr 27; 28(2):560. PubMed ID: 8623270 [No Abstract] [Full Text] [Related]